Human Pathology
Volume 34, Issue 1 , Pages 18-27 , January 2003

Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: Correlation with microvessel density and clinicopathologic features

,Accepted 18 September 2002.

References 

  1. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931–10934
  2. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst. 1990;82:4–6
  3. Ellis LM, Fidler IJ. Tumor angiogenesis. In: ed 2.  Mendelsohn J,  Howley PM,  Israel MA, et al. editor. The Molecular Basis of Cancer. Philadelphia, PA: Saunders; 2001;p. 173–185
  4. Shebert GV, Lakshmi MS. Angiogenesis in cancer. In:  Shebert GV,  Lakshmi MS editor. The Genetics of Cancer: Genes Associated With Cancer Invasion, Metastasis and Cell Proliferation. San Diego, CA: Academic Press; 1997;p. 86–99
  5. Chan ASY, Leung SY, Wong MP, et al.  Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependimoma. Am J Surg Pathol. 1998;22:816–826
  6. Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietin and VEGF. Oncogene. 1999;18:5356–5362
  7. Solcia E, Capella C, Klöppel G. Tumors of the pancreas. In:  Rosai J,  Sobin LH editor. Atlas of Tumor Pathology. Tumors of the Pancreas. Washington, DC: Armed Forces Institute of Pathology; 1997;p. 145–209
  8. Solcia E, Capella C, Fiocca R, et al.  Disorders of the endocrine system. In: ed 2.  Ming SC,  Goldman H editor. Pathology of the Gastrointestinal Tract. Baltimore, MD: Williams & Wilkins; 1998;p. 295–322
  9. La Rosa S, Uccella S, Capella C, et al.  Localization of acidic fibroblast growth factor, fibroblast growth factor receptor-4, transforming growth factor-α, and epidermal growth factor receptor in human endocrine cells of the gut and related tumors: An immunohistochemical study. Appl Immunohistochem. 1998;6:199–208
  10. Rindi G, Azzoni C, La Rosa S, et al.  ECL-cell tumor and poorly differentiated endocrine carcinoma of the stomach: Prognostic evaluation by pathological analysis. Gastroenterology. 1999;116:532–542
  11. La Rosa S, Uccella S, Capella C, et al.  Localization of hepatocyte growth factor and its receptor met in endocrine cells and related tumors of the gut and pancreas: An immunohistochemical study. Endocr Pathol. 2000;11:315–329
  12. La Rosa S, Uccella S, Erba S, et al.  Immunohistochemical detection of fibroblast growth factor receptors in normal endocrine cells and related tumors of the digestive system. Appl Immunohistochem Mol Morphol. 2001;9:319–328
  13. Christofori G, Naik P, Hanahan D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol Endocrinol. 1995;9:1760–1770
  14. Kuroda M, Oka T, Oka Y, et al.  Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cells. J Clin Endocrinol Metab. 1995;80:3196–3200
  15. Terris B, Scoazec Y, Rubbia L, et al.  Expression of vascular endothelial growth factor in digestive neuroendocrine tumors. Histopathology. 1998;32:133–138
  16. Decaussin M, Sartelet H, Robert C, et al.  Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-flt1 and VEGF-R2-flk1/KDR) in non-small cell lung carcinomas (NSCLCs): Correlation with angiogenesis and survival. J Pathol. 1999;188:369–377
  17. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147:9–19
  18. Bosari S, Lee AKC, DeLellis RA, et al.  Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 1992;23:755–761
  19. Fan L, Iseki S. Immunohistochemical localization of vascular endothelial growth factor in the endocrine glands of the rat. Arch Histol Cytol. 1998;61:17–28
  20. Seo Y, Baba H, Fukuda T, et al.  High expression of vascular endothelial growth factor is associated with liver metastasis and poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer. 2000;88:2239–2245
  21. Berse B, Brown LF, Water LVD, et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 1992;3:211–220
  22. Brown LF, Berse B, Jackman RW, et al.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 1993;53:4727–4735
  23. Shrifen JL, Doldi N, Ferrara N, et al.  In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: Implications for mode of action. J Clin Endocrinol Metab. 1994;79:316–322
  24. Rooman I, Schmit F, Bouwens L. Effect of vascular endothelial growth factor on growth and differentiation of pancreatic ductal epithelium. Lab Invest. 1997;76:225–232
  25. Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 1997;57:765–772
  26. Bonner-Weir S. The microvasculature of the pancreas, with emphasis on that of the islets of Langerhans. Anatomy and functional aspects. In: ed 2.  Go VLW,  DiMagno EP,  Gardner JD, et al. editor. The Pancreas: Biology, Pathobiology and Disease. New York, NY: Raven; 1993;p. 759–768
  27. Öberg C, Waltenberger J, Claesson-Welsh L, et al.  Expression of protein kinases in islet cells: Possible role of the flk-1 receptor for β-cell maturation from duct cells. Growth Factor. 1994;10:115–126
  28. Goto F, Goto K, Weindel K, et al.  Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest. 1993;69:508–517
  29. Rofstad EK, Halsor EF. Vascular endothelial growth factor, interleukin-8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Cancer Res. 2000;60:4932–4938
  30. Xin X, Yang S, Ingle G, et al.  Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol. 2001;158:1111–1120
  31. Ahlman H, Wanberg B, Nilsson O. Growth regulation in carcinoid tumors. Endocrinol Metab Clin North Am. 1993;22:889–915
  32. Yarden Y. Growth factor receptor tyrosine kinases. Ann Rev Biochem. 1988;57:443–478
  33. Von Marchall Z, Cramer T, Höcker M, et al.  De novo expression of vascular endothelial growth factor in human pancreatic cancer: Evident for an autocrine mitogenic loop. Gastroenterology. 2000;119:1358–1372
  34. Fidler IJ. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990;50:6130–6138
  35. Bossi P, Viale G, Lee AKC, et al.  Angiogenesis in colorectal tumors: Microvessel quantitation in adenomas and carcinomas with clinicopathological correlation. Cancer Res. 1995;55:5049–5053
  36. Cioc AM, Perez-Montiel D, Ellison EC, et al.  Correlation between microvascular density, histopathology, and outcome in neuroendocrine tumors of the pancreas. Mod Pathol. 2002;15:113A

☆ Supported in part by a grant from the University of Insubria.

☆☆ Address correspondence and reprint requests to Professor Carlo Capella, Servizio di Anatomia Patologica, Ospedale di Circolo, Viale Borri 57, I-21100 Varese, Italy.

PII: S0046-8177(03)00011-X

doi: 10.1053/hupa.2003.56

Human Pathology
Volume 34, Issue 1 , Pages 18-27 , January 2003

Article Tools

* Image Usage & Resolution